Podcast Episodes
Back to Search
Pharmaceutical Executive Daily: Direct-To-Consumer Trends
In today’s Pharmaceutical Executive Daily, we cover Takeda’s new multi-year research collaboration with Nabla Bio, how tariff and pricing pressures a…
7 months, 1 week ago
Advancing Neuroscience and Rare Disease Innovation
Acadia Pharmaceuticals’ CEO Catherine Owen Adams discusses the current climate in R&D and details her leadership style.
7 months, 1 week ago
Pharmaceutical Executive Daily: Policy Whiplash
In today’s Pharmaceutical Executive Daily, we cover Ypsomed’s new North Carolina manufacturing site, how pharma leaders are maintaining strategic cla…
7 months, 1 week ago
Pharmaceutical Executive Daily: Most Favored Nation Order's Evolving Landscape
In today’s Pharmaceutical Executive Daily, we cover Bristol Myers Squibb’s $1.5 billion acquisition of Orbital Therapeutics, ongoing legal and market…
7 months, 1 week ago
Pharmaceutical Executive Daily: Why DSCSA Compliance is Only The Beginning
In today’s Pharmaceutical Executive Daily, we cover the FDA’s approval of Johnson & Johnson’s Simponi for pediatric ulcerative colitis, why DSCSA com…
7 months, 1 week ago
Pharmaceutical Executive Daily: Amgen Launches New Direct-To-Consumer Platform
In today’s Pharmaceutical Executive Daily, we explore why medical AI success depends on more than algorithms, Amgen’s launch of its new direct-to-con…
7 months, 1 week ago
Pharmaceutical Executive Daily: FDA Lifts Clinical Hold on NUZ-001
In today’s Pharmaceutical Executive Daily, we cover the FDA lifting its clinical hold on Neurizon Therapeutics’ lead program Nuz-001, the agency’s ex…
7 months, 2 weeks ago
Pharmaceutical Executive Daily: Updated Vaccine Recommendations
Welcome to Pharmaceutical Executive Daily, your quick briefing on the top news shaping the pharmaceutical and life sciences industry. In today’s Phar…
7 months, 2 weeks ago
Pharmaceutical Executive Daily: FDA's new Fast-Track Review
In today’s Pharmaceutical Executive Daily, we cover the FDA’s new fast-track review program for U.S.-made generics, Novartis’ FDA approval of Rhapsid…
7 months, 2 weeks ago
Pharmaceutical Executive Daily: President Trump Pauses Tariff Plan
Stay informed on key pharmaceutical news, including tariff updates, FDA shutdown risks, and insights from recent cell and gene therapy reviews.
7 months, 2 weeks ago